RT Journal Article
SR Electronic
T1 Rule learning in adolescents at clinical high risk for psychosis shows altered patterns of activation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.01.20.20018069
DO 10.1101/2020.01.20.20018069
A1 Joseph M. Orr
A1 Jesus Lopez
A1 Michael J. Imburgio
A1 Andrea Pelletier-Baldeli
A1 Jessica A. Bernard
A1 Vijay A. Mittal
YR 2020
UL http://medrxiv.org/content/early/2020/03/31/2020.01.20.20018069.abstract
AB Background The ability to flexibly apply rules to novel situations is a critical aspect of adaptive human behavior. While executive function deficits are known to appear early in the course of psychosis, it is unclear which specific facets are affected. Identifying whether rule learning is impacted at the early stages of psychosis is necessary for truly understanding the etiology of psychosis and may be critical for designing novel treatments. Therefore, we examined rule learning in healthy adolescents and those meeting criteria for clinical high risk (CHR) for psychosis.Methods 24 control and 22 CHR adolescents underwent rapid, high-resolution fMRI while performing a paradigm which required them to apply novel or practiced task rules.Results Previous work has suggested that practiced rules rely on rostrolateral prefrontal cortex (RLPFC) during rule encoding and dorsolateral prefrontal cortex (DLPFC) during task performance, while novel rules show the opposite pattern. We failed to replicate this finding, with greater activity for novel rules during performance. Comparing the HC and CHR group, there were no statistically significant effects, but an effect size analysis found that the CHR group showed less activation during encoding and greater activation during performance. This suggests the CHR group may use less efficient reactive control to retrieve task rules at the time of task performance, rather than proactively during rule encoding.Conclusions These findings suggest that flexibility may be altered in the clinical high risk state, however, more data is needed to determine whether these deficits predict disease progression.Competing Interest StatementVAM is a consultant to Takeda Pharmaceuticals. The other authors have no competing interestsFunding StatementThis work was funded by the National Institute of Mental Health R01MH094650 to V.A.M.. J.M.O. was supported by F32DA034412 and by start-up funds from Texas A&M University. J.A.B. was supported by NIH F32MH102898, a Brain & Behavior Research Foundation NARSAD Young Investigator Award as the Donald & Janet Boardman Family Investigator, and by start-up funds from Texas A&M University.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesBehavioral data and analysis scripts are available on Open Science Framework (https://osf.io/snuqj/). Raw imaging data are available on OpenNeuro (doi://10.18112/openneuro.ds001371.v1.0.0). Final statistical results are available on BALSA (https://balsa.wustl.edu/Klv19). Additional information about symptoms and demographics are not publicly available, but can be made available by contacting author VAM. https://osf.io/snuqj/ https://openneuro.org/datasets/ds001371 https://balsa.wustl.edu/Klv19